Diversified Trust’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$503K Sell
8,571
-9,204
-52% -$386K 0.01% 748
2026
Q1
$573K Sell
17,775
-6,319
-26% -$234K 0.01% 651
2025
Q4
$1.01M Buy
24,094
+2,029
+9% +$81.8K 0.02% 440
2025
Q3
$757K Buy
22,065
+13,196
+149% +$379K 0.02% 490
2025
Q2
$240K Buy
8,869
+29
+0.3% +$840 0.01% 820
2025
Q1
$262K Sell
8,840
-8,209
-48% -$313K 0.01% 774
2024
Q4
$675K Sell
17,049
-15,612
-48% -$591K 0.02% 499
2024
Q3
$1.11M Buy
32,661
+4,601
+16% +$129K 0.03% 352
2024
Q2
$608K Buy
28,060
+5,200
+23% +$109K 0.02% 474
2024
Q1
$507K Buy
22,860
+8,050
+54% +$196K 0.02% 509
2023
Q4
$407K Buy
14,810
+575
+4% +$13.9K 0.01% 560
2023
Q3
$318K Buy
14,235
+2,825
+25% +$72.7K 0.01% 597
2023
Q2
$291K Sell
11,410
-75
-0.7% -$1.82K 0.01% 639
2023
Q1
$256K Sell
11,485
-85
-0.7% -$2.05K 0.01% 684
2022
Q4
$275K Sell
11,570
-680
-6% -$15.8K 0.01% 612
2022
Q3
$203K Buy
12,250
+425
+4% +$9.56K 0.01% 700
2022
Q2
$235K Buy
11,825
+1,225
+12% +$24.7K 0.01% 642
2022
Q1
$292K Buy
10,600
+1,525
+17% +$43.6K 0.01% 633
2021
Q4
$374K Buy
9,075
+1,050
+13% +$46.4K 0.01% 554
2021
Q3
$373K Buy
8,025
+900
+13% +$39.3K 0.01% 505
2021
Q2
$285K Buy
7,125
+1,541
+28% +$65.9K 0.01% 565
2021
Q1
$300K Buy
+5,584
New +$322K 0.01% 540

Other funds holding VCYT

Diversified Trust's VCYT Position: Q2 2026 in Review

Diversified Trust reduced its Veracyte (VCYT) stake by 52% in Q2 2026, selling an estimated $386K and leaving 8,571 shares worth $503K. The position accounts for 0.01% of the portfolio, ranked #748.

Diversified Trust first reported a position in VCYT in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.11M in Q3 2024. 24 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Diversified Trust held 8,571 shares of Veracyte worth $503K as of Q2 2026.
  • Diversified Trust sold 9,204 Veracyte shares in Q2 2026, an estimated $386K.
  • Veracyte made up 0.01% of Diversified Trust's portfolio in Q2 2026, its #748 holding.
  • Diversified Trust first reported a position in Veracyte in Q1 2021 and has held it in 22 quarters since.
  • Diversified Trust's Veracyte position peaked at $1.11M in Q3 2024.
  • 24 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.